Share Facebook Twitter LinkedIn Pinterest Email T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands
Anthropic IPO prospectus reveals surging costs, $42B 2025 net loss: report (ANTHRO:Private)September 29, 2026